RedX Pharma plc (REDX) Ordinary Shares 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Jounce agrees Concentra Bioscences takeover, ditches Redx Pharma
27 March 2023 14:16
(Sharecast News) - Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.
Company announcements Announcements
-
Result of AGM
14 March 2024 11:27
Redx Pharma
-
Redx to Exhibit Three Posters at AACR
6 March 2024 07:00
Redx Pharma
-
First Participant Dosed in Phase 1 Trial of RXC008
28 February 2024 07:00
Redx Pharma
-
New Grant of Options
23 February 2024 07:00
Redx Pharma
-
Notice of AGM
16 February 2024 16:50
Redx Pharma
-
Statement re Press Report
14 February 2024 07:00
Redx Pharma
-
TR-1: Notification of major holdings
8 February 2024 13:02
Redx Pharma
-
Redx announces sale of KRAS inhibitor program
7 February 2024 07:00
Redx Pharma
-
Final Audited Results for Year Ended 30 September
15 December 2023 07:00
Redx Pharma
-
Notice of Preliminary Results
12 December 2023 07:00
Redx Pharma
-
Holdings in Company
9 November 2023 07:00
Redx Pharma
-
TR-1: Notification of major holdings
8 November 2023 13:58
Redx Pharma
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.